Search by Drug Name or NDC
NDC 42291-0475-60 Lubiprostone 8 ug/1 Details
Lubiprostone 8 ug/1
Lubiprostone is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is LUBIPROSTONE.
Product Information
| NDC | 42291-0475 |
|---|---|
| Product ID | 42291-475_f7a613ca-8beb-ef3f-e053-6294a90a14e7 |
| Associated GPIs | |
| GCN Sequence Number | 063946 |
| GCN Sequence Number Description | lubiprostone CAPSULE 8 MCG ORAL |
| HIC3 | D6S |
| HIC3 Description | LAXATIVES AND CATHARTICS |
| GCN | 99658 |
| HICL Sequence Number | 033451 |
| HICL Sequence Number Description | LUBIPROSTONE |
| Brand/Generic | Generic |
| Proprietary Name | Lubiprostone |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Lubiprostone |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 8 |
| Active Ingredient Units | ug/1 |
| Substance Name | LUBIPROSTONE |
| Labeler Name | AvKARE |
| Pharmaceutical Class | Chloride Channel Activator [EPC], Chloride Channel Activators [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209450 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 42291-0475-60 (42291047560)
| NDC Package Code | 42291-475-60 |
|---|---|
| Billing NDC | 42291047560 |
| Package | 60 CAPSULE in 1 BOTTLE (42291-475-60) |
| Marketing Start Date | 2023-01-04 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |